Cite
HARVARD Citation
van Koningsbruggen-Rietschel, S. et al. (n.d.). Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patients. Journal of antimicrobial chemotherapy. pp. 711-717. [Online].